Related Experiment Video
Updated: Aug 23, 2025

06:11
Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
1.9K
A Digital Microfluidic RT-qPCR Platform for Multiple Detections of Respiratory Pathogens
Huitao Huang1, Kaisong Huang1, Yun Sun2
1Zhuhai Center for Disease Control and Prevention, Zhuhai 519087, China.
Micromachines
|October 27, 2022
Summary
A new digital microfluidic (DMF) RT-qPCR platform enables simultaneous detection of eleven respiratory pathogens. This cost-effective system offers high sensitivity and specificity for improved diagnostics in resource-limited settings.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Infectious Disease Research
Background:
- The COVID-19 pandemic highlights the critical need for rapid, accurate diagnostics to control infectious disease spread.
- Traditional nucleic acid detection methods like RT-PCR require specialized labs and personnel, limiting accessibility in remote areas.
- Digital microfluidic (DMF) technology offers a promising alternative for multiplexed pathogen detection with reduced sample requirements and simplified operation.
Purpose of the Study:
- To develop and validate a novel digital microfluidic (DMF) based RT-qPCR platform for the simultaneous detection of multiple respiratory pathogens.
- To assess the diagnostic performance of the DMF platform against established off-chip RT-PCR methods.
Main Methods:
- Development of a novel digital microfluidic (DMF) platform integrated with RT-qPCR for multiplexed nucleic acid detection.
- Simultaneous detection of eleven key respiratory pathogens, including SARS-CoV-2, influenza viruses, and other common respiratory agents.
- Evaluation of diagnostic performance using positive plasmid samples and clinical specimens, comparing results with individual off-chip RT-PCR.
Main Results:
- The DMF RT-qPCR platform demonstrated high diagnostic accuracy, with a true positive rate of 93.33% and true negative rate of 100%.
- The system achieved excellent performance metrics, including 100% positive predictive value, 99.56% negative predictive value, and 99.85% overall accuracy.
- The limit of detection ranged from 12 to 150 copies per test, indicating high sensitivity for pathogen identification.
Conclusions:
- The developed on-chip DMF RT-qPCR system is a cost-effective, highly sensitive, and specific solution for multiplex respiratory pathogen detection.
- This technology significantly enhances the potential for timely and effective clinical management of respiratory infections, particularly in resource-limited settings.
- The DMF platform offers a user-friendly and efficient alternative to conventional methods, improving accessibility to advanced diagnostics.

